US Health Department is ending 22 contracts for mRNA vaccine development worth nearly $500 million The decision aligns with Secretary Robert F Kennedy Jr's shift in vaccine strategy mRNA vaccines from Moderna and Pfizer remain FDA approved for COVID-19 prevention
